Alnylam Pharmaceuticals
ALNY
#579
Rank
NZ$57.34 B
Marketcap
$446.65
Share price
1.16%
Change (1 day)
52.17%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividends for this company